Stem Cell Innovation At Risk In UK, Studies Find

Despite great hopes for stem cell therapy, major structural and cultural changes within the UK's National Health Service are needed if it is to succeed in the UK. Currently the chances of getting effective treatments into routine use in the short-term are small and the industry is at serious risk of 'market failure'. These are the findings of two major studies into the commercialisation and adoption of stem cell therapy.

Read the whole article on Science Daily

More from Science Daily